OVERVIEW
The role of targeted therapy continues to expand in the oncology setting, with antibody-drug conjugates (ADCs) comprising one of the more recent advances for the management of solid tumors. Join us for our 75-minute, engaging symposium to learn more about the unique mechanism of action of these ADCs, the latest targets and advances, and clinical application of data from recent clinical trials in solid tumors. Our expert faculty will highlight key perspectives and strategies through didactic lecture, case presentations, and panel discussions. Expanded engagement is provided by an expert faculty member who will be available to interact directly with online audience members during the symposium and connect with interested participants for 30 minutes following the live event. All participants will be able to engage in interactive polling throughout the symposium.
GOAL STATEMENT
The goal of this activity is for learners to be better able to understand the dynamic potential of ADC therapies in the treatment of patients with solid tumors.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have increased knowledge regarding the [LIST] [ITEM]Mechanism of ADC therapy [ITEM]Clinical trial data evaluating ADCs for the treatment of solid tumors[/LIST] Have greater competence related to [LIST] [ITEM]Accurately identifying patients that would be eligible to receive ADCs for the treatment of solid tumors [ITEM]Individualizing care for patients receiving ADCs for the treatment of solid tumors[/LIST] Demonstrate greater confidence in their ability to [LIST] [ITEM]Incorporate emerging ADC data into the clinical care of patients with solid tumors[/LIST]
ACCREDITATION STATEMENT
[JALOGO][MEDSCAPE] In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.25 [italic][bold]AMA PRA Category 1 Credit(s)™[/bold][/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Rosen Centre Hotel
Room: Grand Ballroom A
9840 International Drive
Orlando, Florida, 32819
United States
This symposium is sponsored by Medscape Oncology and supported by a grant from Sanofi and Seagen, Inc. This is not an official program of the American Association for Cancer Research Annual Meeting.
Supported by an independent educational grant from [bold] Sanofi and Seagen, Inc. [/bold]